Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive45

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive27

Views

Views
January 20250
February 20253
March 202516
April 20252
May 20252
June 20253
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States5
Argentina2
Brazil1
Spain1
United Kingdom1
Hong Kong1
 

Top cities views

Views
Buenos Aires1
Council Bluffs1
Cumming1
Hong Kong1
Mendoza1
São Paulo1